Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-21-016345
Filing Date
2021-07-02
Accepted
2021-07-02 16:07:11
Documents
1
Period of Report
2021-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 6125
  Complete submission text file 0001437749-21-016345.txt   7592
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Issuer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EPIZYME, INC. 400 TECHNOLOGY SQUARE, 4TH FLOOR CAMBRIDGE MA 02139
Business Address
Ho Peter Tai-Ching (Reporting) CIK: 0001619052 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36361 | Film No.: 211070015